FDA Grants Tentative Approval for Liquidia ’s Yutrepia (treprostinil) Inhalation Powder

First dry-powder formulation of treprostinil to meet criteria required for FDA approval Final FDA approval may occur in October 2022 or earlier upon resolution of on-going litigation MORRISVILLE, N.C., Nov. 08, 2021 (GLOBE NEWSWIRE) --...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news